CompletedPhase 3NCT00002727
Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Andy M. Trotti, MDH. Lee Moffitt Cancer Center and Research Institute
- Intervention
- radiation therapy(radiation)
- Enrollment
- 250 target
- Eligibility
- 18-120 years · All sexes
- Timeline
- 1996 – 2016
Study locations (30)
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
- Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
- Huntsville Hospital System, Huntsville, Alabama, United States
- MBCCOP - Gulf Coast, Mobile, Alabama, United States
- Alabama Oncology, LLC, Montgomery, Alabama, United States
- DCH Cancer Treatment Center, Tuscaloosa, Alabama, United States
- Foundation for Cancer Research and Education, Phoenix, Arizona, United States
- Mount Diablo Medical Center, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Saint Agnes Cancer Center, Fresno, California, United States
- California Cancer Center, Fresno, California, United States
- Sutter Health West Cancer Research Group, Greenbrae, California, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002727 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →